TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ASND

Ascendis Pharma AS

Healthcare · Biotechnology

228.10$ -0.9% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Ascendis Pharma AS (ASND) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,302 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ASND
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
23 25 27 59 132 190 211 319 677 980 1,085 1,090 826 1,179 1,302
18 21 21 53 126 184 205 293 611 740 806 923 703 1,061 1,109
16 15 19 50 120 180 195 278 598 585 446 445 392 560 616
16 15 19 50 120 180 195 278 598 719 682 735 399 560 616
2.0 5.7 1.7 1.3 1.1 0.3 0.2 0.0 0.8 0.4 2.2 12 36 166 158
– – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75 131 209 296 301
– – 2.0 2.7 2.4 2.4 2.6 4.3 45 108 126 129 – – –
3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5
– – – 3.5 3.5 301,964 3.5 4.6 4.4 2.2 1.8 1.3 0.9 0.5 0.2
23 24 20 13 11 13 24 39 80 141 201 826 971 1,285 1,465
22 24 20 13 11 13 24 39 48 53 100 717 737 908 1,069
0.2 0.2 – 0.0 0.0 0.0 0.0 0.0 5.9 6.9 14 427 435 492 486
2.5 2.5 2.5 5.0 8.4 13 17 20 28 22 59 101 95 96 91
– – – 0.0 0.0 0.0 0.0 0.0 0.0 – 98 483 534 365 385
0.2 1.6 6.3 46 120 177 187 280 597 839 884 263 -146 -106 -163
-3.2 -1.9 2.1 40 111 -139 -263 -393 -611 -1,030 -1,236 -1,860 -2,277 -2,560 -2,699
– 11 11 17 24 27 34 41 47 51 55 56 56 58 61

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?